Skip to content

DR. JOHN VAN OVERSCHELDE

Active
Private limited companyfounded 200817 yrs activeHoezekouterdreef 119, 9300 Aalst, BelgiumKBO/BCE: BE 0807.967.636

DR. JOHN VAN OVERSCHELDE has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €323k and a net result of €58k. Equity is growing by ~10.6% per year across the filed fiscal years. Its solvency ranks better than 46% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
85 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability54▼-7
Solvency83=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 2.54 against 2.97 in 2024; short-term debt: 24.2% and cash: 43.9% of total assets), and 41.6% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
58.4%
Return on assets
10.5%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 17 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-05-2026, 84 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
84 d early
2024
89 d early
2023
79 d early
2022
89 d early
2021
60 d early
2020
31 d late
2019
31 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€323k▼ 3.7%
2024 · €335k
2018: €181k 2019: €210k 2020: €164k 2021: €183k 2022: €255k 2023: €297k 2024: €335k
2018 → 2025
Total assets
€552k▼ 4.3%
2024 · €577k
2018: €570k 2019: €569k 2020: €428k 2021: €420k 2022: €549k 2023: €539k 2024: €577k
2018 → 2025
Net result
€58k▼ 12.9%
2024 · €67k
2018: €97k 2019: €89k 2020: €70k 2021: €69k 2022: €72k 2023: €42k 2024: €67k
2018 → 2025
Working capital
€206k▼ 0.8%
2024 · €207k
2018: €103k 2019: €111k 2020: €48k 2021: €76k 2022: €120k 2023: €167k 2024: €207k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€183k-€255k▲ 39.3%€297k▲ 16.6%€335k▲ 12.6%€323k▼ 3.7%
Operating result€104k-€108k▲ 4.0%€137k▲ 27.3%€155k▲ 12.8%€158k▲ 2.0%
Net result€69k-€72k▲ 4.8%€42k▼ 41.0%€67k▲ 57.3%€58k▼ 12.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150kOperating result 2021: €104k€104kNet result 2021: €69k€69kOperating result 2022: €108k€108kNet result 2022: €72k€72kOperating result 2023: €137k€137kNet result 2023: €42k€42kOperating result 2024: €155k€155kNet result 2024: €67k€67kOperating result 2025: €158k€158kNet result 2025: €58k€58k20212022202320242025
The operating result has risen four years in a row; 2025 is 2% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €552k
Fixed assets €213k▼ 19.5%
Current assets €339k▲ 8.6%
Equity and liabilities €552k
Equity €323k▼ 3.7%
Debt €230k▼ 5.2%
The debt ratio falls from 42.0% to 41.6%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€213k
2024 · €210k
Cash flow
€113k
2024 · €122k
Solvency
58.4%
2024 · 58.0%
Current ratio
2.54
2024 · 2.97
Quick ratio
2.54
2024 · 2.97
Debt / equity
0.71
2024 · 0.72
ROE
18.0%
2024 · 19.9%
ROA
10.5%
2024 · 11.6%
Interest coverage
2.67
2024 · 3.30
Debt
€230k
2024 · €242k
Debt ≤ 1 year
€134k
2024 · €105k
Debt > 1 year
€96k
2024 · €137k
Income taxes
€26k
2024 · €29k
Staff costs
€7k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€577k€552k
Fixed assets21/28€265k€213k
Tangible fixed assets22/27€264k€212k
Land and buildings22€195k€168k
Plant, machinery and equipment23€4k€922
Furniture and vehicles24€64k€44k
Financial fixed assets28€1k€1k=
Current assets29/58€312k€339k
Amounts receivable within one year40/41€108k€66k
Other amounts receivable41€108k€66k
Current investments50/53€50k€15k
Cash at bank and in hand54/58€144k€243k
Deferred charges and accrued income490/1€10k€15k
Equity and liabilities
Total equity and liabilities10/49€577k€552k
Equity10/15€335k€323k
Contributions10/11€12k€12k=
Reserves13€322k€310k
Tax-exempt reserves132€413€413=
Distributable reserves133€322k€310k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€242k€230k
Amounts payable after more than one year17€137k€96k
Financial debts170/4€137k€96k
Amounts payable within one year42/48€105k€134k
Current portion of amounts payable after more than one year42€46k€45k
Trade debts44€18k€7k
Suppliers440/4€18k€7k
Taxes, remuneration and social security45€12k€11k
Taxes450/3€7k€6k
Remuneration and social security454/9€5k€5k=
Other amounts payable47/48€29k€70k
Accrued charges and deferred income492/3€0€563
Income statement Code20242025
Remuneration, social security and pensions62-€7k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€55k€55k
Other operating charges640/8€3k€2k
Gross operating margin9900€212k€222k
Operating profit (loss)9901€155k€158k
Financial income75/76B€4k€5k
Recurring financial income75€4k€5k
Financial charges65/66B€63k€80k
Recurring financial charges65€63k€80k
Profit (loss) for the period before taxes9903€96k€84k
Income taxes67/77€29k€26k
Profit (loss) for the period9904€67k€58k
Profit (loss) for the period to be appropriated9905€67k€58k
Appropriation of the result
Profit (loss) to be appropriated9906€67k€58k
Transfer from equity791/2€31k€72k
Transfer to equity691/2€69k€60k
To other reserves6921€69k€60k
Profit to be distributed694/7€29k€70k
Return on contributions (dividend)694€29k€70k

The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
08-05
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
03-05
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
13-05
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Weakest financial yearnet €42k ▼41%
Net result drops to €42k, the lowest in the series; recovery starts the following year.
03-05
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Equity above €200kEq €255k ▲39.3%
5 profitable years in a row build equity to €255k.
01-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
31-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 31 days late
2019
31-12
Financial Equity above €200kEq €210k ▲15.8%
2 profitable years in a row build equity to €210k.
23-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 23 days late
2018
29-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 29 days late
2017
26-06
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Aalst · 1 establishment unit since 2008
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Hoezekouterdreef 1199300 Aalst
Ground area
1,235 m²
Building footprint
232 m²
Parcel 41002B0081/00K000, Flanders. Linked by address, not a title deed.
1 establishment unit
DR. JOHN VAN OVERSCHELDE
Hoezekouterdreef 119, 9300 AalstSpecialist medical practice
since 20082.253.398.486
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
41002B0081/00K000 Flanders 1,235 m² 1 · 232 m² -
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

25490096YHTOIQR3L098
live in the LEI register

Similar companies · same sector, comparable size

Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 6,642 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded25-11-2008
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
68203Renting and operating of own or leased non-residential real estate, excluding land
90029Arts creation and performing arts activities
90399Other support activities for arts and performing arts
Sources
Crossroads Bank for EnterprisesNational Bank · 17 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.